{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:37:49Z","timestamp":1770291469916,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nmd.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T02:20:09Z","timestamp":1543026009000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunoglobulin (Ig)G-4 related myositis \u2013 A new entity?"],"prefix":"10.1016","volume":"29","author":[{"given":"Vincent","family":"Casteleyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3593-1449","authenticated-orcid":false,"given":"Torsten","family":"Diekhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2018.11.009_bib0001","first-page":"491","article-title":"Autoimmune pancreatitis and IgG4-related systemic diseases","volume":"3","author":"Zhang","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/1756-185X.12863","article-title":"IgG4-related retroperitoneal fibrosis: a newly characterized disease","volume":"19","author":"Lian","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.nmd.2018.11.009_bib0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.semarthrit.2013.11.008","article-title":"Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review","volume":"43","author":"Wallace","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nmd.2018.11.009_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.anl.2011.01.023","article-title":"A novel concept of Mikulicz's disease as IgG4-related disease","volume":"39","author":"Himi","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.nmd.2018.11.009_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2018.11.009_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0007","doi-asserted-by":"crossref","first-page":"e8710","DOI":"10.1097\/MD.0000000000008710","article-title":"Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: a case report and literature review","volume":"96","author":"Anan","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.nmd.2018.11.009_bib0008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2018.11.009_bib0009","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1212\/NXI.0000000000000451","article-title":"Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis","volume":"5","author":"Radke","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.nmd.2018.11.009_bib0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0011","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.semarthrit.2017.03.021","article-title":"Disease associations with isolated elevations of each of the four IgG subclasses","volume":"47","author":"Engelhart","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nmd.2018.11.009_bib0012","first-page":"19","article-title":"Diagnosis and treatment of IgG4-related disease","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13075-018-1567-2","article-title":"Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients","volume":"20","author":"Wang","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nmd.2018.11.009_bib0014","unstructured":"Nambiar S, Oliver TI. IgG4 Related Disease (IgG4-RD). 2018."},{"key":"10.1016\/j.nmd.2018.11.009_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/ijnm.IJNM_154_17","article-title":"A rare case of sarcoidosis presenting as diffuse contracturing granulomatous myositis on fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"33","author":"Thulasidoss","year":"2018","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.nmd.2018.11.009_bib0016","first-page":"98","article-title":"Muscle involvement in sarcoidosis: a retrospective and followup studies","volume":"33","author":"Fayad","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6103064","article-title":"Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease","volume":"2018","author":"Karim","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nmd.2018.11.009_bib0018","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1513\/AnnalsATS.201403-128FR","article-title":"Clinical review of pulmonary manifestations of IgG4-related disease","volume":"11","author":"Campbell","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.nmd.2018.11.009_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.nmd.2018.11.009_bib0020","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896618310423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896618310423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:07:41Z","timestamp":1760774861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896618310423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0960896618310423"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2018.11.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoglobulin (Ig)G-4 related myositis \u2013 A new entity?","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}